Mesothelioma, Malignant Clinical Trial
Official title:
Special Drug Use Investigation (Survey) of Yervoy and Opdivo Combination Therapy in Patients With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)
The purpose of this study is to observe the safety of the combination therapy with Yervoy and Opdivo in Japanese participants for the treatment of unresectable advanced/recurrent malignant pleural mesothelioma (MPM).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06057935 -
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
|
Phase 2 | |
| Completed |
NCT02519049 -
11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)
|
||
| Recruiting |
NCT04104776 -
A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05429866 -
Immunological Variables Associated to ICI Toxicity in Cancer Patients
|
Phase 2 | |
| Recruiting |
NCT04981119 -
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
|
||
| Terminated |
NCT02357147 -
Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)
|
Phase 2 | |
| Recruiting |
NCT06281860 -
Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration
|
Phase 1 | |
| Completed |
NCT02303899 -
Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma
|
Phase 2 | |
| Recruiting |
NCT05380713 -
......SMARTEST Trial......
|
Phase 2 | |
| Recruiting |
NCT06299163 -
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT05568680 -
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
|
Phase 1 | |
| Terminated |
NCT03502746 -
Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma
|
Phase 2 | |
| Active, not recruiting |
NCT05451849 -
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06251310 -
SW-682 in Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT05944237 -
HTL0039732 in Participants With Advanced Solid Tumours
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT05455424 -
Niraparib Efficacy in Patient With Unresectable Mesothelioma
|
Phase 2 | |
| Active, not recruiting |
NCT03654833 -
Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma
|
Phase 2 | |
| Recruiting |
NCT05136677 -
A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants
|
Phase 2 | |
| Not yet recruiting |
NCT05698238 -
Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours
|
Phase 1 | |
| Not yet recruiting |
NCT05188859 -
First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
|
Phase 2 |